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Introduction: In the present investigation, microarray analysis was used to monitor transcriptional activity in thy-
roids inmice 24 h after 131I exposure. The aims of this studywere to 1) assess the transcriptional patterns associated
with 131I exposure in normal mouse thyroid tissue and 2) propose biomarkers for 131I exposure of the thyroid.
Methods: Adult BALB/c nude mice were i.v. injected with 13, 130 or 260 kBq of 131I and killed 24 h after injection
(absorbed dose to thyroid: 0.85, 8.5, or 17 Gy). Mock-treated mice were used as controls. Total RNA was extracted
from thyroids and processed using the Illumina platform.
Results: In total, 497, 546, and 90 transcripts were regulated (fold change ≥1.5) in the thyroid after 0.85, 8.5, and
17 Gy, respectively. These were involved in several biological functions, e.g. oxygen access, inﬂammation and im-
mune response, and apoptosis/anti-apoptosis. Approximately 50% of the involved transcripts at each absorbed
dose level were dose-speciﬁc, and 18 transcripts were commonly detected at all absorbed dose levels. The Agpat9,
Plau, Prf1, and S100a8 gene expression displayed amonotone decrease in regulationwith absorbed dose, and further
studies need to be performed to evaluate if they may be useful as dose-related biomarkers for 131I exposure.
Conclusion:Distinct and substantial differences in gene expression and affected biological functionswere detected at
the different absorbed dose levels. The transcriptional proﬁles were speciﬁc for the different absorbed dose levels.
We propose that the Agpat9, Plau, Prf1, and S100a8 genes might be novel potential absorbed dose-related bio-
markers to 131I exposure of thyroid.
Advances in knowledge:During the recent years, genomic techniques have been developed; however, they have not
been fully utilized in nuclearmedicine and radiationbiology.Wehave usedRNAmicroarrays to investigate genome-
wide transcriptional regulations in thyroid tissue inmice after low, intermediate, and high absorbed doses from 131I
exposure in vivo. Using this approach, we have identiﬁed novel biological responses and potential absorbed dose-
related biomarkers to 131I exposure. Our research shows the importance of embracing technological advances and
multi-disciplinary collaboration in order to apply them in radiation therapy, nuclearmedicine, and radiation biology.
Implications on Patient Care: This work may contribute with new knowledge of potential normal tissue effects or
complications that may occur after exposure to ionizing radiation in diagnostic and therapeutic nuclear medicine,
and due to radioactive fallout or accident with radionuclide spread.
© 2014 Elsevier Inc. Open access under CC BY-NC-ND license.1. Background
Iodide is taken up by the thyroid gland and incorporated into thyroid
hormones, crucial for fetal and neonatal central nervous system devel-
opment and in the regulation of metabolic processes [1]. While 127I is
the only stable iodine isotope, several radioactive isotopes exist, and al-
ready in 1941 131I was reported to be suitable for treatment of Graves'
disease [2]. Currently, 131I is routinely used for treatment of thyroid can-
cer and hyperthyroidism (as iodide), and for treatment of other tumour
types (when bound to tumour-seeking agents).46 31 3421378.
t).
-NC-ND license.Cellular responses to irradiation are induced by e.g. a direct hit of the
DNAmolecule or other targets within a cell, radiation-induced free rad-
icals, or as indirect (bystander) response by extracellular signaling
[3–6]. These responses affect gene expression levels and cause tran-
scriptional regulation. Transcriptional proﬁling with microarrays
enables detection of global mRNA variation in tissues in a single exper-
iment. The majority of studies using genome-wide approaches have
been performed in vitro using gamma radiation and often at few
absorbed dose levels or temporal points [7,8]. In contrast, studies per-
formed in vivo have demonstrated complex and distinct dose-
dependent cellular responses following irradiation. Transcriptional
proﬁles of mouse kidneys and brain demonstrated that both tissues
respond in a tissue-speciﬁc manner [9]. We recently demonstrated
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absorbed dose levels of 177Lu exposure induced distinctly different re-
sponses in normal tissues in various mice tissues [10–13]. Furthermore,
thyroid tissue inmice exposed to 0.05–32Gy 211At showed a substantial
difference in the gene expression proﬁles between the absorbed dose
levels [14]. In the same study, 130 genes were regulated at all absorbed
dose levels and may thus potential biomarkers for 211At exposure.
The aims of the current study were to 1) assess the transcriptional
patterns associated with 131I exposure of thyroid tissue in adult mice
and 2) to propose novel biomarkers for 131I exposure of the thyroid. In
the present study, we identiﬁed distinct differences in global transcrip-
tional levels and affected biological processes between the absorbed
dose levels.
2. Methods
2.1. Radionuclide and radioactivity measurements
131I was obtained as NaI from GE Healthcare (Braunschweig,
Germany). A gamma counter (Wallac 1480 Wizard® 3"; Wallac Oy,
Turku, Finland) was used to determine injected activity by measure-
ment of aliquots of the stem solutions.
2.2. Study design
Eight BALB/c nude mice aged 6–8 months were divided into four
groups (n = 2). Animals from 3 groups were injected in the tail vein
with 0.15 ml of 13, 130 or 260 kBq 131I diluted in phosphate-buffered sa-
line (pH 7). The fourth group was mock-treated in the tail vein with
empty syringes. Mice had access to water and standard mouse food ad
libitum. Animals were killed by cardiac puncture under anesthesia with
pentobarbitalnatrium (APL; Kungens Kurva, Sweden) 24 h after injection,
and thyroidswere excised and immediately snap-frozen in liquid nitrogen
and stored at−80 °C until analysis. The study designwas approved by the
Ethical Committee on Animal Experiments in Gothenburg, Sweden.
2.3. Dosimetric calculations
Themedical internal radiation dose (MIRD) [15] formalismwas used
to calculate the thyroid mean absorbed dose,
Dthyroid ¼ A
e
thyroid

X
niEi  фi
mthyroid
:
Ãthyroid is then the cumulated activity in the thyroid, ni is the radia-
tion yield, Ei is the energy, фi is the absorbed fraction for radiation i in
the thyroid, and mthyroid is the thyroid mass. Previously published data
on activity concentration in thyroids were used to determine Ãthyroid
[16]. The data consist of radioactivity measurements at t = 0, 1, 2, 4, 6,
and 24 h on thyroid in mice, and the trapezoidal rule was used to deter-
mine Ãthyroid in the thyroid gland. Only electrons emitted by 131I located
in the thyroid gland were considered, and the фi was set to 0.742 [17].
The absorbed dose to thyroid was 0.85, 8.5, and 17 Gy after injections
of 13, 130 and 260 kBq 131I, respectively.
2.4. Transcriptional analysis
Total RNAwas extracted frompooled thyroids from each group using
the RNeasy Lipid Tissue Mini Kit (Qiagen; Hilden, Germany) and proc-
essed at the Swegene Center for Integrative Biology at Lund University
(SCIBLU) using the MouseRef-8 Whole-Genome Expression BeadChips
(Illumina; San Diego, CA, USA). Raw signal intensities and images were
acquired using the Illumina BeadScan 3.5.31.17122 (Illumina; San
Diego, CA) image analysis software and Illumina BeadArray Reader scan-
ner, respectively. BioArray Software Environment system (BASE) wereused to preprocess data and for quantile normalization of the raw signal
intensities [18]. Further data processing was performed with Nexus Ex-
pression 2.0 (BioDiscovery; El Segundo, CA) to identify regulated tran-
scripts (fold change N1.5) with an FDR-corrected p-value b0.01 using
the Benjamini-Hochberg method [19]. Raw data have been deposited
at NCBI Gene Expression Omnibus (GEO no. GSE54594).
Results from statistical analyses on regulated genes are presented in
the Supplementary Table 1. All genes in the text are considered statistically
signiﬁcant, but p-values are not included in the text to enhance readability.
2.5. Gene ontology analysis
A categorization of detected gene ontology (GO) termsbased on ances-
tor charts that link transcripts to biological function was established
(http://www.geneontology.org) [20]. Eight main categories (with
corresponding subcategories) were used: 1) DNA integrity; 2) gene
expression integrity; 3) cell communication; 4) organismic regulation; 5)
cell cycle and differentiation; 6) metabolic processes; 7) cellular integrity;
8) stress responses.
Statistical analyses results of enriched gene ontology terms are
found in Supplementary Table 3. All terms in the text are considered sta-
tistically signiﬁcant with a p-value b0.05, but p-values are not included
in the text to enhance readability.
3. Results
3.1. Regulated transcripts
The number of statistically signiﬁcant transcripts regulated in the thy-
roid at 24 h after exposure to 0.85, 8.5, and 17 Gy from i.v. injected 131I
was 497, 546, and 90, respectively (Fig. 1A, Supplementary Table 1).
Results from statistical analysis (p-values) are presented in Supplementa-
ry Table 1. The fraction of up-regulated transcripts increased with
absorbed dose, particularly between 8.5 and 17 Gy. Approximately 50%
of the regulated transcripts detected at each absorbed dose level were
dose-speciﬁc (Fig. 1B, Table 1). Among the 852 regulated transcripts
(758 genes), 18 genes were commonly detected at 0.85, 8.5, and 17 Gy
(Table 2). Of these, down-regulation (12 genes) was more prevalent
than up-regulation (4 genes), and two genes (Clec2d and Ccl9) were
down-regulated at 0.85 and 8.5 Gy, but up-regulated at 17 Gy.
3.2. Gene ontology analysis
Regulated transcripts were classiﬁed according to enriched GO
terms and further categorized (Fig. 2, Supplementary Tables 2 and 3).
Results of statistical analysis (p-values) are given in Supplementary
Table 3. The number of affected biological processes was 41 for 17 Gy,
followed by 36 and 31 processes for 0.85 and 8.5 Gy, respectively.
Only one GO term (cell adhesion) was affected at all exposure levels.
GO terms related to DNA and gene expression integrity,
e.g., maintenance of telomeres and transcription, were only detected
at 0.85 Gy. Various growth factor receptor signaling pathways were af-
fected at 0.85 and 8.5 Gy. The SMAD pathway was affected by down-
regulation of Spnb2 at 0.85 Gy and up-regulation of Tob1 at both 0.85
and 17 Gy. Furthermore, the TGF-β receptor signaling pathway was af-
fected at 8.5 Gy, via up-regulation of DOH48114 and down-regulation of
Ltbp4. Exposure to all absorbed dose levels resulted in similar numbers
of detected GO terms for the category cell cycle and differentiation (sub-
categories: apoptotic cell death, cell cycle regulation, and differentiation
and aging).While 0.85 and 8.5 Gy had an impact on negative regulation
of apoptosis, cell cycle regulation was affected at all absorbed dose
levels. Additionally, GO terms related to differentiation and aging were
detected at all exposure levels with regulation of cell growth at 0.85
and 8.5 Gy and negative regulation of cell differentiation at 17 Gy. Var-
ious GO terms related to metabolic processes were detected at all
absorbed doses. More GO terms related to cellular integrity were
Fig. 1. Regulated transcripts in thyroids in mice after 131I exposure. Transcriptional proﬁles in irradiated thyroids were compared with non-irradiated controls. Transcripts with fold
change N 1.5 were considered to be regulated (statistically signiﬁcant). A) Total number of up- (positive number) and down-regulated (negative number) transcripts. As an example: to-
tally 201+296=497 transcriptswere regulated after 0.85Gy exposure. B) Venn-diagram showing the distribution of regulated transcripts. Areas illustrate number of transcripts, e.g. 249
unique transcripts were regulated exclusively after 0.85 Gy; 219 transcripts were regulated after both 0.85 and 8.5 Gy; 11 transcripts were regulated after 0.85 and 17 Gy; and 18 tran-
scripts were regulated at all exposure levels. Total number of regulated transcripts for 0.85 Gy was 249 + 219 + 11 + 18= 497.
265N. Rudqvist et al. / Nuclear Medicine and Biology 42 (2015) 263–268detected at 17 Gy compared with 0.85 and 8.5 Gy. Both 8.5 and 17 Gy
exposure had an impact on the physico-chemical environment, where-
as GO terms related to supramolecularmaintenancewere detected only
at 17 Gy. In the main category cellular response to stress, responses to
hypoxia and toxins were detected at 0.85 and 8.5 Gy, while exposure
to 8.5 Gy also resulted in responses to heat and drugs. While both 8.5
and 17 Gy induced inﬂammation-associated transcript regulation, nine
GO terms related to immune response were detected only after expo-
sure to 17 Gy. These GO terms revealed an immune system related re-
sponse with activation of the complement system, regulation of T and
NK cells, and regulation and activation of macrophages. Additionally, a
general defense and stress response was detected at 17 Gy.3.3. Biomarkers for radiation exposure
Of the 18 genes with regulated gene expression after all exposures,
the Agpat9, Plau, Prf1, and S100a8 genes displayed a monotoneTable 1
Distribution of regulated transcripts.
Regulation per absorbed dose level⁎ Regul
Numb
0.85 Gy 8.5 Gy 17 Gy
↑ 113
↓ 136
↑ 140
↓ 154
↑ 35
↓ 11
↑ ↑ 75
↑ ↓ 2
↓ ↑ 4
↓ ↓ 138
↑ ↑ 7
↓ ↑ 1
↓ ↓ 3
↑ ↑ 5
↑ ↓ 1
↓ ↑ 6
↓ ↓ 3
↑ ↑ ↑ 4
↓ ↓ ↑ 2
↓ ↓ ↓ 12
Total number of transcripts 852
⁎ ↓ and ↑ indicate down- and up-regulation, respectively.
† The number of transcripts that belong to one speciﬁc group.
‡ The fraction of the total number of transcripts detected at each absorbeddose level is deﬁned
of transcripts regulated at that speciﬁc absorbed dose level, e.g. 113 (transcripts exclusively upre
equals 22.7%.regulation of expression with absorbed dose (Fig. 3). Previously sug-
gested 102 biomarkers for radiation were evaluated in the present
dataset (Table 3) [7,8,21,22]. The majority of these genes (88/102)
were not detected at any absorbed dose level in our data, and none of
the gene was detected at all absorbed dose levels. Apaf1, Bbc3, Cxcl12,
and Gadd45gwere regulated at 0.85 Gy, whereas Acta2, Hspe1were ex-
clusively regulated at 8.5 Gy. Ccnd1was exclusively regulated at 8.5 and
17 Gy. Furthermore, Amy1, Cdkn1a, Ephx2, Fos, Gadd45a, Jun, Stat1were
regulated only at 0.85 and 8.5 Gy.4. Discussion
Many regulated transcripts were detected primarily after exposure
to 0.85 or 8.5 Gy. Down-regulation was prominent after 0.85 and
8.5 Gy, whereas up-regulation was more common after 17 Gy. Approx-
imately 50% of the regulated transcripts at each absorbed dose level
were dose-speciﬁc, suggesting that dose-dependent pathways areated transcripts
er† Number/Total number of transcripts‡
0.85 Gy 8.5 Gy 17 Gy
22.7%
27.4%
25.6%
28.2%
38.9%
12.2%
15.1% 13.7%
0.4% 0.4%
0.8% 0.7%
27.8% 25.3%
1.4% 7.8%
0.2% 1.1%
0.6% 3.3%
0.9% 5.6%
0.2% 1.1%
1.1% 6.7%
0.5% 3.3%
0.8% 0.7% 4.4%
0.4% 0.4% 2.2%
2.4% 2.2% 13.3%
497 546 90
as the number of transcripts that belong to one speciﬁc group divided by the total number
gulated after 0.85 Gy) divided by 497 (total number of transcripts regulated after 0.85 Gy)
Table 2
Genes differentially regulated at all absorbed dose levels (0.85, 8.5 and 17 Gy).
Fig. 3.Absorbed dose-related regulation of genes. Agpat9, Plau, Prf1, S100a8were differential-
ly regulated at 0.85, 8.5, and 17 Gy with a monotone decrease in differential regulation with
absorbed dose. Agpat9, Plau, and Prf1were down-regulated while S100a8was up-regulated.
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means that approximately 50% of the detected transcripts at each
absorbed dose level were found atmore than one dose level, suggesting
similarities in the transcriptional response between absorbed dose
levels even though only 18 unique transcripts were regulated at all
absorbed dose levels. It is not likely that themeasured response is an ef-
fect from the chemical properties of iodine, because an injected amount
of 13–260 kBq equals only 13–260×109 iodine atoms, whilemice have a
dietary intake in themagnitude of 1018 iodine atoms per day from stan-
dard laboratory chow.
To our knowledge, no previous studies have been performed where
the transcriptional response is measured in normal thyroid tissue
in vivo after 131I exposure. However, comparison of the transcriptional
response between normal and cancer thyroid tissue have been per-
formed in a Chernobyl cohort, but without using un-irradiated controls
[22]. In a previous study where we investigated the thyroid response
after 211At administration in a similar animal model, the fraction of
dose-speciﬁc transcripts decreasedwith increased absorbed dose, dem-
onstrating one of the differences in response between 131I and 211At
[14]. Additionally, of the 18 genes commonly regulated after 131I expo-
sure, only Clec2d, Akam, Ccdc3,Dbp, and S100a8were detected at four or
more (out of ﬁve) absorbed dose levels in the previous 211At study. OneFig. 2. Affected biological processes. Transcriptional changes associated with changes in
biological functions using gene ontology terms (statistically signiﬁcant, p b 0.05). These
terms were categorized using eight main categories (shown in the graph) and 22 subcat-
egories (Supplementary Table 2).reason for differences in the transcriptional response between 131I
and 211At is the difference in radiation quality of themajor contributing
particles with high-LET alpha particles emitted by 211At and low-LET
electrons emitted by 131I. Another difference is themore heterogeneous
energy deposition delivered from 211At compared with 131I. Additional-
ly, 211Atwill deposit the sameabsorbed dose butwith a higher dose-rate
due to shorter physical half-life compared with 131I.
Several genes were detected at 0.85 Gy and play a role in the regula-
tion of DNA and gene expression integrity, aswell as in response to hyp-
oxia, toxin, drug, and heat. On the other hand, an acute response related
to the immune system (17 Gy: 13 genes) and inﬂammation (8.5 Gy: 8
genes; 17 Gy: 3 genes) were observed at 0.85 and 17 Gy. Studies that
mainly used high absorbed doses from external radiation sources have
shown that ionizing radiation causes inﬂammation and activation of
the immune system [23]. It is not clear how and if the inﬂammatory
and immune system machinery is affected at low absorbed doses
or how properties of the radiation source matters, e.g. if there
are differences in response between external radiation exposure
(e.g., radiation therapy and diagnostic radiology) and internal exposure
(e.g., radionuclides used for diagnostics or therapy in nuclearmedicine).
However, studies have shown that the inﬂammatory and immune re-
sponse to irradiation is tissue speciﬁc, and since radionuclides usually
are heterogeneously distributed in an organism, large differences in in-
ﬂammatory and immune response can be anticipated [24]. In the pres-
ent study, no inﬂammation-associated GO terms were detected after
0.85 Gy, and no immune system related responses were detected after
0.85 and 8.5 Gy. This suggests that high absorbed doses are more likely
to affect inﬂammatory and immunological processes on the transcrip-
tional level or that these processes may function without de novo
protein synthesis. Interestingly, we have previously shown that few in-
ﬂammatory and immunological responses are activated in mouse thy-
roids in vivo following 211At exposure (0.05–32 Gy) [14]. These
ﬁndings indicate that mouse thyroid tissue responds differently to 131I
and 211At, maybe partly due to differences in radiation quality and
dose distribution.
In the present investigation, the Edn1, Angptl4, Casp1 andMb genes
involved in hypoxia were regulated after 0.85 and 8.5 Gy. The Edn1
encoded protein is a potent vasoconstrictor while theMb gene encodes
for the myoglobin protein, an O2 storage molecule and intracellular O2
transporter with observed expression in striated muscular tissue [25].
The mRNA levels of Edn1 andMb were down-regulated after exposure
to 0.85Gy. If themRNA levels reﬂect protein levels, these results suggest
a reduction in vasoconstriction and less available O2 transporters and
storage molecules in the analyzed tissue. Knock-out mice lacking the
Mb gene responded to a hypoxic condition by widening blood vessels
in heart tissue [25]. Further studies should test the hypothesis that at
Table 3
Validation of 102 previously proposed radiation-related biomarkers.
Absorbed dose Gene
0.85 Gy Apaf1, Bbc3, Cxcl12, Gadd45g
8.5 Gy Acta2, Hspe1
0.85 and 8.5 Gy Amy1, Cdkn1a, Ephx2, Fos, Gadd45a, Jun
8.5 and 17 Gy Ccnd1
0.85, 8.5 and 17 Gy -
Genes not detected
in the present data
Amy2, Apaf1, Atf3, Bag-1, Batf3, Bax, Bbc3,
Btg2, Ccl26, Ccna2, Ccnb1, Ccnb2, Ccnd1,
Ccne1, Ccng, Ccng1, Cdc20, Cdc25, Cdh5,
Cdkn1a, Csf1, Cx3cl1, Cxcl10, Cxcl11,
Cxcl12, Cxcl5, Cxcl9, Dd2, Ddb2, Ephx2,
Fas, Fcgr1a, Fdxr, Fen1, Fhl2, Flt3, Fos,
Gadd45a, Gadd45g, Gcgr1a, Gja1, Gjb2,
Hiap, Hrad23b, Hspe1, Iap3, Icsbp1, Ifna2,
Il1b, IL-8, Jun (Junb), Lep, Lif,Mak10,
Makp8pi,Mapk1,Mapk3,Mdk,Mdm2,
Myc, Noxa, Ogg1, Osm, Pcna, Pcsk1,
Plcg2, Ppmid, Prkch, Rad51l1, Relb,
Rhoa, Serpine1,Tbfsf4, Tbfrsf10b,
Tgfb3, Tgfbr2, Tnf, Tnfaip8, Tnfrsf10b,
Tnfrsf19, Tnfrsf21, Tnfsf4, Tp53, Tp53i3,
Trp53inp1, Trp53inp2, Ttf, Ube2s,Wee,
Vegfb, Xab2, X-iap, Xpc, Xrcc1, Xrcc6
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gen levels. TheMb genewas up-regulated after exposure to 8.5 Gy, indi-
cating a high amount of oxygen in the analyzed tissue. This is supported
by down-regulation of the Angptl4 gene expression which is induced
during hypoxia [26]. Furthermore, no response to hypoxia was seen
after 17 Gy. Additionally, the Angptl4 gene expression was recurrently
regulated in liver, lungs, kidney cortex and medulla, and spleen 24 h
after injection of 131I or 211At into mice (0.1–1000 mGy) [10,11].
Effects on cell communication and signal transduction through reg-
ulation of several growth factor receptor signaling pathways were seen
after 0.85 and 8.5 Gy. The SMAD pathway was affected by regulation of
the Spnb2 and the Tob1 genes at 0.85 Gy and at 0.85 and 17 Gy, respec-
tively. Furthermore, TGF-β receptor signaling was affected at 8.5 Gy. In-
volvement of signal transduction via the SMAD- and the TGF-β
pathways indicates that several important cell cycle control mecha-
nisms are affected at different absorbed dose levels after 131I exposure.
Negative regulation of apoptosis was seen after 0.85 and 8.5 Gy, and
anti-apoptotic processes were affected at 0.85 Gy but not detected
after 17 Gy. Together, this suggests a change in cellular fate, with regard
to apoptosis, when the absorbed dose increases.
One of the major functions of the thyroid is to produce thyroid hor-
mones containing iodine. The SLC5A5 gene encodes for the sodium-
iodide symporter (NIS) and is partly responsible for transport of iodine
and, to some extent, astatine into the thyroid follicle cells [27]. Previous
studies have demonstrated NISmRNA down-regulation in cultured thy-
roid epithelial cells one and ﬁve days after 0.5 Gy exposure to 131I and
211At, respectively [28]. Additionally, in the same system, iodide trans-
port was immediately elevated and then reduced at 2–7 days after
0.5 Gy of exposure to after 99mTc, 125I, 131I, and 211At with most signiﬁ-
cant changes after 211At exposure [28]. No deregulation of Slc5a5 was
seen in the present investigation or after 211At exposure in a previous
study; however, the Slc5a8 gene which shares 70% sequence homology
with SLC5A5 in humanswas down-regulated at 1.4 Gy but up-regulated
after 211At exposure of 0.05, 0.5, 11, and 32Gy [14]. In the present inves-
tigation, regulation of previously published thyroid hormone synthesis
associated genes were not detected (Tshr, Slc5a5/NIS, Slc26a4/Pendrin,
Tg,Duox2, Tpo, Slc16a2/Mct8, Clc5, Slc5a8/Smct1, andCftr) [29]. The iden-
tiﬁed transcriptional response in the thyroid is generated from a combi-
nation of different cell types. However, it is estimated that 70–80%of the
cells in thyroid tissue are thyrocytes [30]. Together, these resultsindicate that the thyroid function is less affected at the transcriptional
level 24 hours after administration of 131I than 211At.
Few of the 102 genes previously proposed as radiation exposure bio-
markers found in the literaturewere detected in the present investigation
[7,8,21,22]. None of the 102 genes was regulated at all absorbed doses,
and 88 genes were not regulated at any absorbed dose level. Among the
previously proposed biomarkers, the Acta2, Bbc3, Cdkn1a, and Gadd45a
genes were also regulated in the present study, however not at all
absorbed doses levels [21]. The 102 genes were derived primarily from
in vitro and/or ex vivo studies, which may explain the discordance be-
tween the previous studies and the present study in addition to the differ-
ences in radiation quality. In the present study, the transcription factor
Stat3 was down-regulated at 0.85 and 8.5 Gy. This gene is involved in
the regulation of cell proliferation and cell death and was down-
regulated in thyroid tumor patients exposed to 0.3–1 Gy from 131I re-
leased in conjunction with the Chernobyl incident [22].
The Agpat9, Plau, Prf1, and S100a8 genes were monotonously regu-
lated in the present investigation, i.e. increasing or decreasing gene ex-
pression with absorbed dose throughout the entire absorbed dose
range. The Prf1 gene, involved in T-cell mediated cytolysis, belongs to
the autoimmune thyroid disease signaling pathway, and the S100a8
gene product may induce apoptosis under inﬂammatory condi-
tions [31,32]. These genes are interesting biomarker candidate genes
thatmight be useful to predict absorbed dose to thyroid inmice injected
with 131I, at least in the interval 0.85–17 Gy. Their usefulness to predict
absorbed dose should, however, be further evaluated and validated in
larger studies. Further work is also needed to validate their function in
the response to 131I exposure.
5. Conclusion
In the present investigation, transcriptional microarray analysis was
performed to evaluate changes in transcriptional activity in mouse thy-
roid tissues in vivo 24 h after i.v. administration of 131I. Distinct and sub-
stantial differences in gene expression and affected biological functions
were detected at the different absorbed dose levels. Furthermore, the
majority of detected genes were dose-speciﬁc, and few genes were
commonly detected at all absorbed doses. We propose that the
Agpat9, Plau, Prf1, and S100a8 genes might be novel potential absorbed
dose-related biomarkers for 131I exposure. In addition, few previously
proposed radiation-related biomarkers were detected in the present
dataset, most probably since they were primarily identiﬁed in in vitro
studies performed on several cell types, not only thyrocytes.
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